Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study.
Matthias PreusserTomáš KazdaEmilie Le RhunFelix SahmMarion SmitsJens GemptJohan Af KoekkoekAngelo F MontiMarcell CsanadiJános György PitterHelen BulbekBeatrice FournierCaroline QuoilinThierry GorliaMichael WellerGiuseppe Minnitinull nullPublished in: Trials (2024)
ClinicalTrials.gov NCT05904119. Registered before start of inclusion, 23 May 2023.